scispace - formally typeset
P

Pedro S. Coelho

Researcher at California Institute of Technology

Publications -  18
Citations -  1677

Pedro S. Coelho is an academic researcher from California Institute of Technology. The author has contributed to research in topics: Cyclopropanation & Catalysis. The author has an hindex of 10, co-authored 18 publications receiving 1404 citations.

Papers
More filters
Journal ArticleDOI

Olefin Cyclopropanation via Carbene Transfer Catalyzed by Engineered Cytochrome P450 Enzymes

TL;DR: E engineered variants of cytochrome P450BM3 that catalyze highly diastereo- and enantioselective cyclopropanation of styrenes from diazoester reagents via putative carbene transfer are reported, highlighting the capacity to adapt existing enzymes for the catalysis of synthetically important reactions not previously observed in nature.
Journal ArticleDOI

Enzymatic functionalization of carbon–hydrogen bonds

TL;DR: The most prevalent mechanistic strategies used by enzymes to functionalize non-acidic C-H bonds are discussed, the application and evolution of these enzymes for chemical synthesis, and a number of potential biosynthetic capabilities uniquely enabled by these powerful catalysts are discussed.
Journal ArticleDOI

A Serine-Substituted P450 Catalyzes Highly Efficient Carbene Transfer to Olefins In Vivo

TL;DR: A unique serine-heme ligated cytochrome “P411” that catalyzes efficient and selective carbene transfers from diazoesters to olefins in intact Escherichia coli cells is designed.
Journal ArticleDOI

Enantioselective intramolecular C-H amination catalyzed by engineered cytochrome P450 enzymes in vitro and in vivo.

TL;DR: Engineered variants of cytochrome P450_(BM3) have now been found to catalyze intramolecular C-H aminations in azide substrates, with mutations to two highly conserved residues significantly increased this activity.
Journal ArticleDOI

Improved cyclopropanation activity of histidine-ligated cytochrome P450 enables the enantioselective formal synthesis of levomilnacipran.

TL;DR: A highly active His-ligated variant of P450-BM3 that can be employed for the enantioselective synthesis of the levomilnacipran core was engineered and catalyzes the cyclopropanation of N,N-diethyl-2-phenylacrylamide with an estimated initial rate of over 1000 turnovers per minute.